DVLP (Golden Developing Solutions) Accounts Payable & Accrued Expense: $0.00 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Golden Developing Solutions Accounts Payable & Accrued Expense?

Golden Developing Solutions DVLP -90.00% Accounts Payable & Accrued Expense is $0.00 Mil as of Jun. 2023.

Golden Developing Solutions's quarterly accounts payable & accrued expense increased from Dec. 2022 ($0.17 Mil) to Mar. 2023 ($1.15 Mil) but then declined from Mar. 2023 ($1.15 Mil) to Jun. 2023 ($0.00 Mil).

Golden Developing Solutions's annual accounts payable & accrued expense declined from Dec. 2020 ($0.20 Mil) to Dec. 2021 ($0.20 Mil) and declined from Dec. 2021 ($0.20 Mil) to Dec. 2022 ($0.17 Mil).


Golden Developing Solutions Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Golden Developing Solutions's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Golden Developing Solutions Accounts Payable & Accrued Expense Chart

Golden Developing Solutions Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Accounts Payable & Accrued Expense
0.10 0.20 0.20 0.17

Golden Developing Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.00 0.17 1.15 0.00

Golden Developing Solutions Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $0.00 Mil mean?
Golden Developing Solutions (DVLP) has a Accounts Payable & Accrued Expense of $0.00 Mil as of Jun. 2023. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Golden Developing Solutions and its competitors.
Is Golden Developing Solutions' Accounts Payable & Accrued Expense too high?
Golden Developing Solutions' current Accounts Payable & Accrued Expense is $0.00 Mil.
How does Golden Developing Solutions' Accounts Payable & Accrued Expense compare to CSTF and BLMS?
Golden Developing Solutions' Accounts Payable & Accrued Expense of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Drug Manufacturers company?
A good Accounts Payable & Accrued Expense depends on the Drug Manufacturers industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Golden Developing Solutions and its competitors. Golden Developing Solutions's current Accounts Payable & Accrued Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Developing Solutions stock overvalued right now?
Golden Developing Solutions (DVLP) has a current Accounts Payable & Accrued Expense of $0.00 Mil. The current Accounts Payable & Accrued Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Golden Developing Solutions (DVLP), the current Accounts Payable & Accrued Expense is $0.00 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Golden Developing Solutions Business Description

Address PO Box 460573, Fort Lauderdale, FL, USA, 33346
Golden Developing Solutions Inc is a development-stage company providing business services and/or products supporting Health, Wellness, and Technology. The company is also focused on acquisitions of synergistic companies.